Previous Section | Index | Home Page |
Mr. Yeo: My hon. Friend presents the House with a mouth-watering prospect. Harassing the Government on this issue for a whole year would no doubt mean that the Secretary of State and I would have to joust many times across the Floor of the House. I am extremely attracted by that possibility, but we will have to seek advice from the Government about whether primary legislation would be needed.
Mr. Yeo: My hon. Friend assures me that it would.
The truth is that a pharmacy is much more than a retailer of medicines. It is a source of advice for patients about health issues and the use of medicines. Not surprisingly, supermarkets rely more heavily on locum pharmacists. For that reason, the development of a relationship between patient and pharmacist is less likely to be achieved. In those circumstances, service could be less personal: only a third of supermarkets provide home-delivery services.
Caution should be our watchword before we rush in to accept the OFT recommendation, which will mainly benefit younger and more able-bodied peoplethe very categories for whom the services of a pharmacist are least likely to be needed. The Government amendment refers to
Roger Casale: Will the hon. Gentleman give way?
Mr. Yeo: The hon. Gentleman is too late.
The Government's close links with the big supermarkets are well known. Their reluctance to defend small post offices is a scandal. Their refusal to support village shops shows contempt for the needs of rural areas. Their refusal to introduce honesty in food labelling hurts British farmers. Their policy on genetically modified crops is concerned more with the demands of multinational companies than with the need to protect the environment.
Every one of those shabby climbdowns bodes ill for the decision that they must take in relation to the OFT report. I hope that, for once, principle rather than expediency will be the basis of the Government's approach. I hope that they will think of local communities before donations to party funds, and that they will at last put patients' interests first.
I commend the motion to the House.
The Secretary of State for Trade and Industry (Ms Patricia Hewitt): I beg to move, To leave out from "House" to the end of the Question, and to add instead thereof:
I welcome, too, the belated recognition from the hon. Member for South Suffolk (Mr. Yeo) that there are limits to markets, especially in health care. That is quite a conversion from the party that gave us the iniquities of the internal market. I welcome the concern expressed by the Opposition for the health of our communitiesnot something that we heard from the Conservatives when they were devastating our coalfield communities with their onslaught on the mining industry.
Mr. Greg Knight (East Yorkshire): Will the Secretary of State tell the House why she moved an amendment to our motion? Unusually, but not uniquely, the Opposition motion does not attack the Government; it is a statement in support of community pharmacies. Why cannot the Secretary of State accept the motion? What have community pharmacies to fear from her plans?
Ms Hewitt: We are improving on the Opposition motion. I have made plain, and will continue to do so, my support and the Government's support for community pharmacies. The amendment reflects the
approach that we will take, not merely as we consider the report from the Office of Fair Trading but, more important, as we implement the programme for pharmaciesthe modernisation and strengthening of community pharmacies that the Department of Health has put forward.
Mr. Mark Todd (South Derbyshire): My right hon. Friend has indicated that this is an opportunity neither for conservativism or Conservativism, but a chance to work with pharmacists on an agenda for change; for example, by looking into the costs and inefficiencies of patient packs, a subject of great concern to many pharmacists.
Ms Hewitt: My hon. Friend is right. In a moment, I shall come to some of the many improvements that can be made to build on the work that community pharmacies are doing already.
In contrast to the rather aggressive attitude adopted by the hon. Member for South Suffolk, I hope that all of us, on both sides of the House, can agree on the vital role that community pharmacies play. We all use them; we all rely on their advice. They help people to lead healthier lives and to live longer. They play a vital role in our communities and are a lifeline, especially for our most elderly, frail and vulnerable citizens, and all of uswithout the need to make partisan pointsshould support them.
Brian Cotter (Weston-super-Mare): I thank the Secretary of State for those words. May I offer an example of the importance of local pharmacies, which confirms that we are all concerned about these serious issues? Last year, Milton pharmacy in my constituency paid out £1,355 on taxi services to supply free delivery of prescriptions to old people and the very ill. I have a copy of the bill. The pharmacy provides an excellent service and I hope that the Secretary of State's awareness of that will help to inform her decisions.
Ms Hewitt: I welcome the hon. Gentleman's point and the way in which he made it. That example illustrates exactly the kind of service that should be much more widely offered. Home deliveries, especially for elderly or isolated patients, are exactly the sort of service that we want to develop.
Like the hon. Gentleman and hon. Members on both sides of the House, I, too, have met pharmacists from my constituency who are extremely concerned about the possible implications of the OFT report for their services and their businesses: for instance, Mr. Mattock, who runs a pharmacy just down the road from my constituency office, serving a diverse and disadvantaged ward in my constituency; and my constituent, Mr. Mehta, who is a pharmacist in a Leicestershire village. Both of them are wholly committed to serving their patients and their communities, and of course both of them brought me petitions like those received by almost every Member.
I want to make it clear to our community pharmacists that we value their contribution. We value their role as trained clinicians. Above all, we understand the contribution that they make to deprived and remote communities.
We will do nothing that jeopardises that contribution. Indeed, as the hon. Member for Croydon, South (Richard Ottaway) made plain in his excellent quotation, we spelt out in the Department of Health document, "Pharmacy in the Future", that we want to increase and enhance the contribution that pharmacists make as clinicians and professionals in the national health service.
Mr. Steen: The Secretary of State says that she wants to improve local pharmacists' facilities, but does she plan to increase the £18,000 a year that the Government pay for the NHS contract to each pharmacy? Will that sum increase? If it does, pharmacists will be delighted, but they will not be so pleased if she gets rid of it.
Ms Hewitt: My hon. Friend the Minister for Public Health is discussing with pharmacists a new contract and funding through primary care trusts to ensure that they can innovate and that pharmacy services are responsive to the local needs of their community, because the needs of rural communities will be very different from those of deprived inner-city areas. As "Pharmacy in the Future" says, pharmacy is one of the primary health professions in the NHS; it is an integral part of most people's experience of NHS care, whether in the community or in hospital. It was very clear from the responses that the Department of Health received to that document that the public believe that more use could and should be made of pharmacists' skills and expertise.
Mr. David Drew (Stroud): My right hon. Friend has hit exactly the right note. When I met my local pharmacists to discuss their concerns about the OFT report, they said that they very much welcomed the Government's proactive agenda, but they also want to take a very much more active role in respect of prescriptions. They argue that millions of pounds could be saved with a different prescription policy, particularly in relation to repeat prescriptions. We should be following that up, rather than having a sterile debate on whether pharmacies should continue regardless.
Next Section
| Index | Home Page |